Liadova T. I.

№2' 2019
INFECTIOUS DISEASES
Volobuieva O. V., Shustval M. F., Liadova T. I., Volobuiev D. O.
State of lipid peroxidation and antioxidant system in patients with chicken pox
70 - 75
№3' 2017
CARDIOLOGY
Shustval M. F., Volobuieva O. V., Liadova T. I., Mishchuk N. E.
Blood plasma lipids and hormonal changes in patients with coronary atherosclerosis
5 - 10
№1' 2017
INFECTIOUS DISEASES
Liadova T. I., Volobuieva O. V., Gololobova O. V., Shepylieva N. V.
The types of immune response in different forms of Epstein − Barr virus infection
70 - 76
№2' 2016
INFECTIOUS DISEASES
Shustval M. F., Volobuieva O. V., Liadova T. I.
Diagnosis and treatment of herpes virus myocarditis in adults with chickenpox
87 - 92
№2' 2014
INFECTIOUS DISEASES
Shustval N. F., Lyadova T. I., Volobuyeva O. V.
Cardiac complications in infectious mononucleosis in adults
90 - 95
№1' 2014
INFECTIOUS DISEASES
Malyi V. P., Boyko V. V., Liadova T. I., Gololobova O. V.
Clinical characteristics of the course of viral hepatitis A depending on the genotype of HAV and type of immune response
75 - 80
№1' 2012
INFECTIOUS DISEASES
Malyi V. P., Liadova T. I., Volobuyeva O. V., Gololobova O. V.
Molecular epidemiology of obligatory hepatotropic viruses and their influence on the clinical manifestations and outcome of the disease
89 - 94
№1' 2011
INFECTIOUS DISEASES
Malyi V. P., Boyko V. V., Liadova T. I.
Clinical peculiarities of the course of viral hepatitis A depending on its genotype and the type of the organism immune response
95 - 98
№4' 2009
INFECTIOUS DISEASES
Maliy V. P., Liadova T. I., Volobuyeva O. V.
Modern trends in drug treatment for herpesvirus infections
76 - 79
№4' 2008
INFECTIOUS DISEASES
Maly V. P., Nartov P. V., Liadova T. I.
Lactoferrin amount in cerebrospinal fluid of patients with acute meningitis
81 - 84
№2' 2008
INFECTIOUS DISEASES
Maly V. P., Volobuyeva O. V., Liadova T. I.
Amebiasis: clinical manifestations, diagnosis, therapy
110 - 117
№3' 2006
PULMONOLOGY
Malyi V. P., Liadova T. I., Yekimova N. A., Vlasova A. I.
Tebris efficacy in complex treatment for non−hospital pneumonia
54 - 57
Go on Top